Business Description
Ju Fu Tang Biotech Holdings Co Ltd
ISIN : KYG5700C1087
Total Employee Number:
23Compare
Compare
Traded in other countries / regions
08217.Hong Kong IPO Date
2016-04-12Description
Ju Fu Tang Biotech Holdings Co Ltd is an investment holding company. The group's reportable segments are: i) Provision of civil engineering, decoration and renovation works: delivery of civil-engineering, decoration and renovation projects together with related maintenance services, and ii) Health technology business: sale of medical devices products. The majority of revenue is derived from the Provision of civil engineering, decoration and renovation works segment. Geographically, the Group's operations are located in the Hong Kong and the People's Republic of China (the PRC).
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 5.05 | |||||
Equity-to-Asset | 0.55 | |||||
Debt-to-Equity | 0.24 | |||||
Debt-to-EBITDA | 0.5 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.24 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -29.2 | |||||
3-Year EPS without NRI Growth Rate | 2.4 | |||||
3-Year FCF Growth Rate | -37.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 69.02 | |||||
9-Day RSI | 56.47 | |||||
14-Day RSI | 49.62 | |||||
3-1 Month Momentum % | -46.46 | |||||
6-1 Month Momentum % | -68.16 | |||||
12-1 Month Momentum % | -58.28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.2 | |||||
Quick Ratio | 2.2 | |||||
Cash Ratio | 1.44 | |||||
Days Sales Outstanding | 194.45 | |||||
Days Payable | 234.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 2.71 | |||||
Operating Margin % | -20 | |||||
Net Margin % | 62.09 | |||||
EBITDA Margin % | 64.01 | |||||
FCF Margin % | 20.8 | |||||
OCF Margin % | 20.8 | |||||
ROE % | 55.34 | |||||
ROA % | 25.72 | |||||
ROIC % | -43.75 | |||||
3-Year ROIIC % | -6.66 | |||||
ROC (Joel Greenblatt) % | 14868.87 | |||||
ROCE % | 57.05 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 1.43 | |||||
PS Ratio | 0.87 | |||||
PB Ratio | 0.64 | |||||
Price-to-Tangible-Book | 0.63 | |||||
Price-to-Free-Cash-Flow | 4.12 | |||||
Price-to-Operating-Cash-Flow | 4.12 | |||||
EV-to-EBIT | -0.68 | |||||
EV-to-EBITDA | -0.68 | |||||
EV-to-Revenue | -0.44 | |||||
EV-to-FCF | -2.09 | |||||
Price-to-GF-Value | 0.71 | |||||
Price-to-Projected-FCF | 0.45 | |||||
Price-to-Median-PS-Value | 2.68 | |||||
| Price-to-Net-Current-Asset-Value | 0.63 | |||||
| Price-to-Net-Cash | 1.78 | |||||
Earnings Yield (Greenblatt) % | -147.06 | |||||
FCF Yield % | 24.18 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ju Fu Tang Biotech Holdings Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 37.555 | ||
| EPS (TTM) (HK$) | 0.075 | ||
| Beta | 1.5821 | ||
| 3-Year Sharpe Ratio | 0.23 | ||
| 3-Year Sortino Ratio | 0.47 | ||
| Volatility % | 67.01 | ||
| 14-Day RSI | 49.62 | ||
| 14-Day ATR (HK$) | 0.010238 | ||
| 20-Day SMA (HK$) | 0.1051 | ||
| 12-1 Month Momentum % | -58.28 | ||
| 52-Week Range (HK$) | 0.075 - 0.405 | ||
| Shares Outstanding (Mil) | 301.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ju Fu Tang Biotech Holdings Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ju Fu Tang Biotech Holdings Co Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| 0.25:1 Stock Split | 2021-09-13 | 0.27 (+5.41%) | ||
| 0.25:1 Stock Split | 2020-03-18 | 0.43 (+0.00%) |
Show
Entries
Ju Fu Tang Biotech Holdings Co Ltd Frequently Asked Questions
What is Ju Fu Tang Biotech Holdings Co Ltd(HKSE:08217)'s stock price today?
The current price of HKSE:08217 is HK$0.11. The 52 week high of HKSE:08217 is HK$0.41 and 52 week low is HK$0.08.
When is next earnings date of Ju Fu Tang Biotech Holdings Co Ltd(HKSE:08217)?
The next earnings date of Ju Fu Tang Biotech Holdings Co Ltd(HKSE:08217) is .
Does Ju Fu Tang Biotech Holdings Co Ltd(HKSE:08217) pay dividends? If so, how much?
Ju Fu Tang Biotech Holdings Co Ltd(HKSE:08217) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Ju Fu Tang Biotech Holdings Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers